Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Centre for Medicinal Cannabis (CMC) is a London-based industry body and think tank dedicated to the advancement of a regulated and clinically-led medicinal cannabis market in the United Kingdom. The organization works with a coalition of businesses, academics, and policy experts to advocate for better access to cannabis-based medicinal products (CBMPs) and to establish high standards for product quality and safety. CMC provides strategic advice, commissions market research, and engages with regulatory bodies like the MHRA and Home Office to shape the legal framework for the industry. Their work focuses on building the clinical evidence base required for widespread NHS prescription and improving the supply chain for patients. By bridging the gap between the cannabis industry and the UK healthcare system, the CMC aims to facilitate the integration of cannabinoid medicines into mainstream clinical practice.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Centre for Medicinal Cannabis.